Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

244
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
244
Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

839
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
839
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

298
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
298
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

2.1K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.1K
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

442
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
442

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A nationwide multi-centre survey of 12,500 cases of upper gastrointestinal bleeding: A report of Indian Society of Gastroenterology Task Force on acute upper gastrointestinal bleed.

Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology·2026
Same author

Efficacy of Computed Tomography Calcium (CT Ca) Score as a Screening Tool for Coronary Artery Disease in Wait Listed Liver Transplant Recipients.

Journal of clinical and experimental hepatology·2026
Same author

Creation and validation of manometry GERD score to predict positive reflux test (gastroesophageal reflux disease).

Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology·2025
Same author

Dynamic SG-SKRDX hybrid framework for precision weather forecasting and crop suitability in the Cauvery Delta.

Scientific reports·2025
Same author

Cystic Duct Anastomosis as a Rescue Strategy to Deal With a Separated Segment 2 Bile Duct During Right Lobe Donor Hepatectomy With Variant Biliary Anatomy.

Journal of clinical and experimental hepatology·2025
Same author

A Systematic Review and Meta-analysis on CLIF C ACLF Score in Predicting Short-term Mortality in Patients with Acute on Chronic Liver Failure.

Journal of clinical and experimental hepatology·2025

Related Experiment Video

Updated: Feb 25, 2026

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy
07:10

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy

Published on: June 18, 2020

23.0K

HRQOL using SF36 (generic specific) in liver cirrhosis.

K Janani1, Joy Varghese2, Mayank Jain1

  • 1Department of Gastroenterology, Gleneagles Global Health City, 439, Cheran Nagar, Chennai, 600 100, India.

Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology
|August 2, 2017
PubMed
Summary

Liver cirrhosis significantly impacts health-related quality of life (HRQOL), with disease severity and complications lowering scores. Physical health components strongly influence mental well-being in these patients.

Keywords:
CirrhosisLiverQuality of life

Related Experiment Videos

Last Updated: Feb 25, 2026

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy
07:10

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy

Published on: June 18, 2020

23.0K

Area of Science:

  • Hepatology
  • Quality of Life Research
  • Clinical Medicine

Background:

  • Health-related quality of life (HRQOL) is crucial for patients with chronic conditions.
  • Liver cirrhosis and its complications significantly impact a patient's overall well-being.
  • Understanding factors affecting HRQOL in cirrhosis is vital for comprehensive patient care.

Purpose of the Study:

  • To identify factors influencing health-related quality of life (HRQOL) domains in liver cirrhosis patients.
  • To assess the impact of age, comorbidities, disease severity, and complications on HRQOL using the SF-36 questionnaire.
  • To compare HRQOL scores in liver cirrhosis patients with age-gender matched healthy controls.

Main Methods:

  • A cross-sectional study involving 149 liver cirrhosis patients and healthy controls.
  • Utilized the SF-36 questionnaire to assess physical and mental components of HRQOL.
  • Statistical analyses including Kruskal-Wallis (KW) test and linear regression were employed to evaluate influencing factors.

Main Results:

  • Cirrhosis patients exhibited significantly lower SF-36 domain scores compared to controls, except for body pain.
  • Younger patients (<45 years), advanced disease (Child-Turcotte-Pugh C), high MELD scores, and complications were associated with lower body pain scores.
  • Physical component scores (PCS) significantly impacted mental component scores (MCS).
  • Musculoskeletal pain and arthralgia negatively affected physical domains and PCS, while diabetes, hypertension, and hypothyroidism had no significant effect.

Conclusions:

  • Liver cirrhosis substantially diminishes HRQOL, particularly physical functioning and mental well-being.
  • Disease severity (MELD score) and specific complications directly correlate with reduced HRQOL.
  • Targeting physical symptoms and complications is essential for improving the quality of life in liver cirrhosis patients.